Searched for
BIOSIMILAR MEDICINES MARKET
Biocon signs 10-year Brazil supply deal for Pertuzumab breast cancer drugIn a significant move, Biocon has secured a ten-year contract in Brazil for the distribution of Pertuzumab, made possible through its colla...08 Sep, 2026, 08.41 AM IST- Drugmakers may bear sole responsibility for overpricing essential medicines under NPPA proposalThe National Pharmaceutical Pricing Authority aims to hold drug manufacturers solely accountable for the excessive pricing of essential med...29 Aug, 2026, 06.00 AM IST
- Biocon arm gets Japan nod for cancer drug pegfilgrastim biosimilarIn a significant advancement, Biocon Biologics has gained marketing approval for its pegfilgrastim biosimilar in Japan. This vital cancer s...25 Aug, 2026, 10.19 AM IST
- India's pharma sector must shift from cost competitiveness to innovation, global quality: ExpertsFor the growth of India's pharmaceutical sector, prioritizing innovation and advanced manufacturing is essential. Experts indicate that inc...18 Aug, 2026, 12.36 PM IST
- Biocon shares rise 2% after USFDA approval for Yesintek single-dose prefilled autoinjectorBiocon shares rose after its US subsidiary received supplemental FDA approval for Yesintek single-dose prefilled autoinjectors in two stren...18 Aug, 2026, 12.26 PM IST
- Thermo Fisher finds India the perfect lab; lab equipment maker steps up investments as drug companies focus on innovationThermo Fisher Scientific is amplifying its investment footprint in India, driven by the strong anticipated growth in the biosimilars and in...15 Aug, 2026, 01.03 AM IST
- Independence Day 2026: India, which once couldn't make smallpox vaccine, has now crossed a pharma milestone the world can't ignore2026 Independence Day: India's pharmaceutical industry marks a historic milestone with a new drug approval. This achievement reflects decad...10 Aug, 2026, 03.13 PM IST
- Picking the right pharma stock is getting harder; so pick a portfolio: 20 stocks with -23% to +22% downside to upside potentialFor Indian pharma, the regulatory risk is still real. A US FDA inspection can still cause trouble. A plant making an important product or g...10 Aug, 2026, 11.10 AM IST
- These mid-cap stocks with ‘Strong Buy’ & ‘Buy’ recos can rally over 25%, according to analystsA word of caution for all those who have exposure to mid cap stocks or are planning to increase it. Just keep one thing in mind: If there i...06 Aug, 2026, 01.04 PM IST
- India Inc goes on a global shopping spree with a new wishlistIndian companies are increasingly pursuing strategic overseas acquisitions. They now focus on acquiring capabilities and technology rather ...05 Aug, 2026, 01.47 PM IST
- ET Health Conclave 2026: Healthcare leaders reimagine the future of medicine through innovation, prevention and technologyThe ET Health Conclave 2026 celebrated healthcare professionals and institutions. Leaders shared insights on healthcare infrastructure and ...04 Aug, 2026, 04.20 PM IST
- India pharma sector to miss 2030 sales target amid tariff and shipping woes, trade body saysIndia's pharmaceutical industry is expected to reach$80-90 billion by 2030, well below its earlier$130 billion target, as U.S. tariff uncer...04 Aug, 2026, 11.04 AM IST
- Tariff on generic drugs: Loud announcement, little consequence? 7 pharma stocks with upside potential of up to 31%The threat of a US tariff on Indian pharma is no longer a vague fear; or at least that is what President Trump wants us to believe. There i...27 Jul, 2026, 12.52 PM IST
- Explained: What Donald Trump's up to 200% pharma tariffs mean for Indian investorsDonald Trump's announcement of tariffs of up to 200% on pharmaceutical imports triggered a selloff in Indian pharma stocks. However, analys...22 Jul, 2026, 01.58 PM IST
- Trump's Generic Drug Tariffs Explained: What it means for Indian pharma before the 200% stormTrump's generic drug tariffs plan provides Indian drugmakers a two-year duty-free window. This allows companies time to reassess manufactur...22 Jul, 2026, 12.42 PM IST
- Sun Pharma, Cipla & other pharma stocks shed over 2% as Trump announces up to 200% tariffs on generic drugs from 2028Pharma stocks, including Sun Pharma, Cipla, Lupin and Dr Reddy's, fell up to 2.5% after US President Donald Trump announced a phased tariff...22 Jul, 2026, 09.40 AM IST
- These large- and mid-cap stocks can give more than 25% return in 1 year, according to analystsOil is crucial for every part of the Indian economy: From government to consumer, its price impacts spending by every stakeholder. So, till...20 Jul, 2026, 06.05 PM IST
Load More
